Carole Mercier
Wilrijk, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized Trial.
Journal: European urology oncology
Published: December 12, 2025
Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized Trial.
Journal: European urology oncology
Published: December 12, 2025
Reply to: "Beyond 1 Month: A Broader Look at the ROBOMET Trial Results" and "ROBOMET Revisited: Is Stereotactic Body Radiotherapy Truly Effective for Painful Bone Metastases?"
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 08, 2025
Dose-Escalated Stereotactic Versus Conventional Radiotherapy for Painful Bone Metastases (ROBOMET): A Multicenter, Patient-Blinded Randomized Clinical Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 09, 2025
Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial.
Journal: The Lancet. Oncology
Published: February 11, 2025
Stereotactic body radiotherapy (SBRT) as a treatment for localized prostate cancer: a retrospective analysis.
Journal: Radiation oncology (London, England)
Published: October 20, 2024
PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 16, 2024
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.
Journal: European urology oncology
Published: December 21, 2023
Long-Term Results of a Phase 1 Dose Escalation Trial of Ablative Stereotactic Body Radiation Therapy.
Journal: International journal of radiation oncology, biology, physics
Published: July 30, 2023
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial.
Journal: European urology oncology
Published: May 17, 2023
Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate Cancer.
Journal: Frontiers in oncology
Published: January 27, 2022
Last Updated: 09/26/2026